BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5

Lancet Infect Dis. 2022 Dec;22(12):1663-1665. doi: 10.1016/S1473-3099(22)00692-2. Epub 2022 Oct 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19* / prevention & control
  • Humans
  • Neutralization Tests
  • SARS-CoV-2*
  • Vaccine Efficacy

Substances

  • BNT162 Vaccine
  • Antibodies, Viral
  • Antibodies, Neutralizing